Osyris Medical Receives FDA 510(K) For LIPOCONTROL(TM) Laser Assisted Lipolysis System

VILLENEUVE D'ASCQ, France, January 31, 2011 /PRNewswire/ -- Osyris Medical, a leading laser medical company, announced today that it has received clearance from the U.S. Food and Drug Administration for its LIPOCONTROL(TM) system for laser assisted lipolysis. The LipoControl is the latest generation of 980nm diode designed to be a workhorse in the operating room for laser assisted lipolysis. The LipoControl offers "real time" Energy Mapping technology with motion sensing and Energy Memory features included. This patented technology is only available thru Osyris Medical and offers the physician the highest level of control and safety available in today's market.

Philippe Rochon, Vice President of R&D for Osyris Medical comments: "We are glad to bring this new device into the US market. In the current regulatory framework, in which several manufacturers are facing difficulties in the 510(k) process, the clearance of such innovating product tends to emphasize the technological breakthrough made by Osyris Medical with the LipoControl. This is a groundbreaking step in using Laser Assisted Lipolysis technologies for more precise liposuction performance."

In the framework of Osyris Medical international development, the United States registration of LipoControl which has been launched recently outside the US will reinforce the promotion of this new technology. It will also accelerate Osyris Medical international expansion and make Osyris Medical worldwide position stronger.

About Osyris Medical

Based in Lille, France, Osyris Medical is a leading manufacturer for producing emerging technologies within a specific market. The company is internationally recognized for its scientific vision and its capacity to bring innovation on the market. Part of the company activity focuses on skin tightening, body contouring and vein removal procedures that are scientifically proven, clinically validated and has high consumer demand. For more information, please visit: http://www.osyrismedical.com

For further information, please contact: contact.pr@osyris.com